Longitudinal study of intestinal symptoms and fecal continence in patients with conformal radiotherapy for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 5, 2011, Pages 1373-1380

  Geinitz, Hans ^a   Thamm, Reinhard ^a   Keller, Monika ^b   Astner, Sabrina T ^a   Heinrich, Christine ^a   Scholz, Christian ^a   Pehl, Christian ^c   Kerndl, Simone ^a   Prause, Nina ^a   Busch, Raymonde ^d   Molls, Michael ^a   Zimmermann, Frank B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c Medizinische Klinik   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Conformal radiotherapy; Fecal continence; Intestinal bother; Intestinal symptoms; Prostate cancer

Indexed keywords

CONFORMAL RADIOTHERAPY; FECAL CONTINENCE; INTESTINAL BOTHER; INTESTINAL SYMPTOMS; PROSTATE CANCER;

DISEASES; RATING; SURVEYS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DEFECATION URGENCY; DIARRHEA; ENTEROPATHY; FECES INCONTINENCE; FLATULENCE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PAINFUL DEFECATION; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; RECTAL MUCOUS DISCHARGE; RECTUM DISEASE; RECTUM HEMORRHAGE; TENESMUS;

AGED; AGED, 80 AND OVER; DEFECATION; FECAL INCONTINENCE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MUCUS; PREVALENCE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RADIOTHERAPY, CONFORMAL; RECTUM; REGRESSION ANALYSIS;

EID: 79952701607     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.033     Document Type: Article

References (37)

1. National Institutes of Health Consensus Development Panel. Consensus statement: The management of clinically localized prostate cancer. NCI Monogr 1988;7:3-6.
2. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet 1999;353:267-272. (Pubitemid 29088118)
3. Yeoh EE, Botten R, Russo A, et al. Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys 2000;47:915-924. (Pubitemid 30345588)
4. Yeoh EK, Russo A, Botten R, et al. Acute effects of therapeutic irradiation for prostatic carcinoma on anorectal function. Gut 1998;43:123-127. (Pubitemid 28335500)
5. Yeoh EE, Holloway RH, Fraser RJ, et al. Anorectal dysfunction increases with time following radiation therapy for carcinoma of the prostate. Am J Gastroenterol 2004;99:361-369. (Pubitemid 38279882)
6. Yeoh EK, Holloway RH, Fraser RJ, et al. Anorectal function after three- versus two-dimensional radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2009;73:46-52.
7. Heemsbergen WD, Hoogeman MS, Hart GA, et al. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:1011-1018. (Pubitemid 40340896)
8. Wachter S, Gerstner N, Dorner D, et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:91-100. (Pubitemid 34044109)
9. Geinitz H, Zimmermann F, Thamm R, et al. Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer. Radiother Oncol 2006;79:341-347. (Pubitemid 44093762)
10. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993;36:77-97. (Pubitemid 23019450)
11. Roach M III, Hanks G, Thames H Jr., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65:965-974.
12. Fransson P, Bergstrom P, Lofroth PO, et al. Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the Beam-Cath® technique. Int J Radiat Oncol Biol Phys 2006;66:430-438. (Pubitemid 44332735)
13. Staff I, Salner SA, Bohannon R, et al. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy. Cancer 2003;98:2335-2343. (Pubitemid 37466648)
14. Hovdenak N, Karlsdottir A, Sorbye H, et al. Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate. Acta Oncol 2003;42:741-748. (Pubitemid 37445294)
15. Beard CJ, Propert KJ, Rieker PP, et al. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study. J Clin Oncol 1997;15:223-229. (Pubitemid 27020577)
16. Varma JS, Smith AN, Busuttil A. Function of the anal sphincters after chronic radiation injury. Gut 1986;27:528-533. (Pubitemid 16079753)
17. Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 1994;74:2520-2532. (Pubitemid 24320858)
18. Crook J, Esche B, Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual functioning: The patients' perspective. Urology 1996;47:387-394. (Pubitemid 26089520)
19. Hanlon A, Watkins Bruner D, Peter R, et al. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: Comparing late bowel and bladder quality of life symptoms to that of the normal population. Int J Radiat Oncol Biol Phys 2001;49:51-59. (Pubitemid 32041276)
20. Fransson P, Damber JE, Tomic R, et al. Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer 2001;92:3111-3119. (Pubitemid 33136207)
21. Vordermark D, Schwab M, Ness-Dourdoumas R, et al. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol 2003;69:209-214. (Pubitemid 37485882)
22. Koper PC, Jansen P, van Putten W, et al. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: Observations of a randomized trial. Radiother Oncol 2004;73:1-9. (Pubitemid 39304119)
23. Fokdal L, Honore H, Hoyer M, et al. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol 2005;74:203-210. (Pubitemid 40331878)
24. al-Abany M, Helgason AR, Cronqvist A-KA, et al. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys 2005;61:1035-1044.
25. Peeters ST, Hoogeman MS, Heemsbergen WD, et al. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys 2006;66:11-19. (Pubitemid 44175644)
26. Iwamoto T, Nakahara S, Mibu R, et al. Effect of radiotherapy on anorectal function in patients with cervical cancer. Dis Colon Rectum 1997;40:693-697. (Pubitemid 27255951)
27. Kim GE, Lim JJ, Park W, et al. Sensory and motor dysfunction assessed by anorectal manometry in uterine cervical carcinoma patients with radiation-induced late rectal complication. Int J Radiat Oncol Biol Phys 1998;41:835-841. (Pubitemid 28285962)
28. Berndtsson I, Lennernas B, Hulten L. Anorectal function after modern conformal radiation therapy for prostate cancer: A pilot study. Tech Coloproctol 2002;6:101-104.
29. Yeoh EE, Sun W, Russo A, et al. A retrospective study of the effects of pelvic irradiation for gynecological cancer on anorectal function. Int J Radiat Oncol Biol Phys 1996;35:1003-1010. (Pubitemid 26279772)
30. Varma JS, Smith AN, Busuttil A. Correlation of clinical and manometric abnormalities of rectal function following chronic radiation injury. Br J Surg 1985;72:875-878. (Pubitemid 16250663)
31. Kushwaha RS, Hayne D, Vaizey CJ, et al. Physiologic changes of the anorectum after pelvic radiotherapy for the treatment of prostate and bladder cancer. Dis Colon Rectum 2003;46:1182-1188. (Pubitemid 37129555)
32. Fiorino C, Fellin G, Rancati T, et al. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: Preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys 2008;70:1130-1137. (Pubitemid 351296107)
33. Fonteyne V, De Neve W, Villeirs G, De Wagter C, De Meerleer G. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity. Radiother Oncol 2007;84:156-163. (Pubitemid 47284531)
34. Valdagni R, Rancati T, Fiorino C, et al. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT. Int J Radiat Oncol Biol Phys 2008;71:1065-1073.
35. Mason M. What implications do the tolerability profiles of antiandrogens and other commonly used prostate cancer treatments have on patient care? J Cancer Res Clin Oncol 2006;132(Suppl. 1):S27-S35.
36. Elsayed H, Bolling T, Moustakis C, et al. Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon. Strahlenther Onkol 2007;183:617-624. (Pubitemid 350124273)
37. van Lin EN, Kristinsson J, Philippens ME, et al. Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy. Int J Radiat Oncol Biol Phys 2007;67:799-811. (Pubitemid 46215872)